Spots Global Cancer Trial Database for colorectal carcinoma
Every month we try and update this database with for colorectal carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics | NCT04905082 | Breast Carcinom... Colorectal Carc... Lung Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Best Practice Educational Int... Educational Int... Genomic Profile Survey Administ... | 18 Years - | City of Hope Medical Center | |
| Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) | NCT02563002 | Colorectal Carc... | mFOLFOX6 FOLFIRI pembrolizumab bevacizumab cetuximab | 18 Years - | Merck Sharp & Dohme LLC | |
| Collection of Information to Better Understand Young Onset Colorectal Cancer | NCT04489238 | Colorectal Canc... Colorectal Carc... | Risk Factor Que... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Safety Study of 90Y-hMN14 to Treat Colorectal Cancer | NCT00040599 | Colorectal Canc... Colon Cancer Rectal Cancer Colorectal Neop... Colorectal Carc... Colorectal Tumo... | hMN14 (labetuzu... | 18 Years - | Gilead Sciences | |
| 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma | NCT01277406 | Advanced Colore... | 4SC-201(Resmino... FOLFIRI | 18 Years - | 4SC AG | |
| Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer | NCT00288444 | Lung Cancer Soft Tissue Sar... Colorectal Carc... Breast Cancer Prostate Cancer | Lonafarnib Docetaxel | - | Emory University | |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | NCT01640522 | Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase... | Collaborative C... Enhanced usual ... | 18 Years - | University of Pittsburgh | |
| Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | NCT05358249 | KRAS G12C Mutan... Carcinoma, Non-... Carcinoma, Non-... Non-Small Cell ... Non-Small Cell ... Nonsmall Cell L... Colorectal Canc... Colorectal Carc... Colorectal Neop... Colorectal Tumo... Neoplasms, Colo... | JDQ443 trametinib Ribociclib cetuximab | 18 Years - | Novartis | |
| Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma | NCT01210313 | Colorectal Carc... | 18 Years - | Austrian Breast & Colorectal Cancer Study Group | ||
| Collection of Information to Better Understand Young Onset Colorectal Cancer | NCT04489238 | Colorectal Canc... Colorectal Carc... | Risk Factor Que... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | NCT01640522 | Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase... | Collaborative C... Enhanced usual ... | 18 Years - | University of Pittsburgh | |
| A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation | NCT05877599 | Non-small Cell ... Head and Neck S... Colorectal Carc... Pancreatic Aden... Breast Cancer Other Solid Tum... | Autologous, eng... | 18 Years - | Neogene Therapeutics, Inc. | |
| Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities | NCT05447923 | Colorectal Carc... | Educational Int... Fecal Immunoche... Patient Navigat... Questionnaire A... | 45 Years - | Mayo Clinic | |
| Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer | NCT01486251 | Colorectal Carc... | axitinib | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer | NCT00179348 | Alopecia Anxiety Breast Carcinom... Cognitive Side ... Colorectal Carc... Depression Fatigue Lung Carcinoma Nausea and Vomi... Pain Psychological I... Sleep Disorder Weight Change | Quality-of-Life... Yoga | 18 Years - | Albert Einstein College of Medicine | |
| Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) | NCT03078361 | Colorectal Canc... Colorectal Carc... | Immunochemical ... LATINOS CARES T... Standard Interv... | 50 Years - 70 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer | NCT00478634 | Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | RAD001, Cetuxim... | 18 Years - 65 Years | Novartis | |
| Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases | NCT00866944 | Liver Metastase... Colorectal Canc... | Adecatumumab Adecatumumab an... FOLFOX 4 | 18 Years - | Amgen Research (Munich) GmbH | |
| Use of iFOBT in Patients Presenting With Alarm Symptoms of Colorectal Cancer | NCT03367611 | Colorectal Neop... Colorectal Canc... Colorectal Carc... Colorectal Aden... Colorectal Aden... | Immunochemical ... | 40 Years - | University of Aarhus | |
| Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors | NCT04980443 | Colorectal Canc... Colorectal Neop... Colorectal Carc... Colorectal Poly... Colorectal Aden... | CELTiC test | 50 Years - 75 Years | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer | NCT00361244 | Colorectal Carc... | SU011248 Irinotecan Cetuximab | 18 Years - | Massachusetts General Hospital | |
| Testing ONC201 to Prevent Colorectal Cancer | NCT05630794 | Colorectal Aden... Colorectal Carc... Familial Adenom... Multiple Adenom... | Biopsy Biospecimen Col... Colonoscopy Dordaviprone Questionnaire A... Sigmoidoscopy | 18 Years - | National Cancer Institute (NCI) | |
| Legume Diet Satiety Pilot Study | NCT02269631 | Obesity Colorectal Carc... | Legume diet gro... Control diet gr... Smartpill legumes | 40 Years - 70 Years | Emory University | |
| Pharmacokinetics and Metabolic Activation of Capecitabine | NCT01579357 | Metastatic Colo... | blood samples | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer | NCT00361842 | Colorectal Neop... | CPX-1 (Irinotec... | 18 Years - | Jazz Pharmaceuticals | |
| FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer | NCT00724503 | Colorectal Canc... Colorectal Carc... Liver Metastase... | SIR-Spheres ytt... Systemic chemot... | 18 Years - | Sirtex Medical | |
| Cancer Communication Within Hispanic Social Networks | NCT04444232 | Colorectal Carc... | Media Intervent... Survey Administ... | 50 Years - 75 Years | Fred Hutchinson Cancer Center | |
| Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases | NCT03717519 | Colorectal Canc... Colorectal Carc... Stage IV Colon ... | Measurement of ... | 18 Years - 100 Years | Azienda Ospedaliera Universitaria Integrata Verona | |
| Axitinib as Maintenance Treatment in Patients With Metastatic CRC | NCT01483638 | Colorectal Carc... | axitinib placebo | 18 Years - | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | |
| An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin | NCT01816659 | Colorectal Carc... | Metformin ER | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma | NCT02337946 | Colorectal Carc... | oxaliplatin (OX... oxaliplatin (OX... | 20 Years - | Takeda | |
| Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy | NCT02694562 | Colorectal Carc... | 40um Embozene T... | 19 Years - | Boston Scientific Corporation | |
| Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies | NCT00081536 | Colorectal Neop... | Aroplatin (Lipo... | 18 Years - | Aronex Pharmaceuticals | |
| Axitinib as Maintenance Treatment in Patients With Metastatic CRC | NCT01483638 | Colorectal Carc... | axitinib placebo | 18 Years - | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | |
| Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases | NCT00588549 | Colorectal Carc... | 18 Years - | Memorial Sloan Kettering Cancer Center | ||
| Microsatellite Instability in Colorectal Cancers | NCT05162248 | Colorectal Canc... Colorectal Carc... Microsatellite ... Microsatellite ... Microsatellite ... | Microsatellite ... | 18 Years - 100 Years | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | |
| A Web-Based Dyadic Intervention for Colorectal Cancer | NCT05663203 | Colorectal Carc... | Internet-Based ... Interview Survey Administ... Electronic Heal... | 18 Years - | Emory University | |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) | NCT02423954 | Advanced Cancer Pancreatic Canc... Renal Cell Canc... Non Small Cell ... Colorectal Carc... Endometrial Uterine | Temsirolimus Irinotecan Irinotecan + ca... nivolumab | 18 Years - | Western Regional Medical Center | |
| Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors | NCT01329809 | Colorectal Carc... | Recombinant Vac... | 18 Years - | Jennerex Biotherapeutics | |
| Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet | NCT04898842 | Colorectal Canc... Colorectal Neop... Colorectal Carc... Colorectal Aden... Colorectal Canc... Ovarian Cancer Ovarian Neoplas... Metastatic Colo... Metastatic Ovar... Peritoneal Carc... Bowel Obstructi... | Dietary interve... | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust | |
| Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers | NCT03300570 | Colorectal Carc... | Dolcanatide Laboratory Biom... Placebo Adminis... Questionnaire A... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial | NCT04490551 | Colorectal Canc... Colorectal Carc... Colorectal Neop... Colorectal Aden... Colorectal Aden... | Risk-based logi... FIT | 55 Years - 75 Years | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer | NCT04148378 | Colorectal Canc... Colorectal Neop... Colorectal Carc... Colorectal Aden... Colorectal Canc... Colorectal Sarc... | No intervention | - | ProgenaBiome | |
| Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | NCT00107861 | Colorectal Carc... Metastases | Ad.hIFN-β (BG00... | 18 Years - | Biogen | |
| Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth | NCT01632020 | Colorectal Neop... | Placebo Metformin | 18 Years - | University of Arkansas | |
| A Community-Based Educational Intervention to Improve Colorectal Cancer Screening | NCT04392050 | Colorectal Carc... | Interview Focus Group Questionnaire A... | 18 Years - | Thomas Jefferson University | |
| Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma | NCT01380600 | Carcinoma, Colo... | Recombinant Vac... | 18 Years - | SillaJen, Inc. | |
| Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | NCT00107861 | Colorectal Carc... Metastases | Ad.hIFN-β (BG00... | 18 Years - | Biogen | |
| Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps | NCT06376565 | Colorectal Carc... | Best Practice Communication I... Communication I... Communication I... Interview Interview | - | Jonsson Comprehensive Cancer Center | |
| CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | NCT02839954 | Hepatocellular ... Non-small Cell ... Pancreatic Carc... Triple-Negative... Malignant Gliom... Colorectal Carc... Gastric Carcino... | anti-MUC1 CAR-p... | 18 Years - | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study | NCT03546127 | Colorectal Carc... Soft Tissue Sar... | Next Generation... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
| NBI Versus White Light Endoscopy for Optical Characterization of Neoplastic Polyps in the Colorectum | NCT03679429 | Colon Adenoma Colorectal Carc... Hyperplastic Po... Serrated Adenom... | NBI Function | 40 Years - 90 Years | Technical University of Munich | |
| Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. | NCT00305188 | Metastases Colorectal Neop... Colorectal Carc... | Xaliproden (SR5... Placebo Oxaliplatin 5-Fluorouracil Leucovorin | 18 Years - | Sanofi | |
| Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases | NCT01233544 | Colorectal Carc... Liver Metastase... | SBRT or RFA | 18 Years - 90 Years | University of Aarhus | |
| Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients | NCT03152565 | Colorectal Carc... | Avelumab | 18 Years - | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| Incorporating ePrognosis for the Encouragement of Smarter Screening for Breast and Colorectal Cancer in Older Adults | NCT05021172 | Breast Carcinom... Colorectal Carc... | Best Practice Informational I... Questionnaire A... Survey Administ... | 70 Years - | University of California, San Francisco | |
| Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors | NCT02611024 | Advanced Solid ... Glioblastoma Soft Tissue Sar... Endometrial Car... Epithelial Ovar... Mesothelioma Gastroenteropan... SCLC Gastric Carcino... Pancreatic Aden... Colorectal Carc... Neuroendocrine ... | Lurbinectedin Irinotecan | 18 Years - | PharmaMar | |
| Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients, CORAL Study | NCT05410977 | Colorectal Carc... Lynch Syndrome | Biospecimen Col... Electronic Heal... | 18 Years - | Mayo Clinic | |
| Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma | NCT02248805 | Colorectal Carc... | MGD007 | 18 Years - | MacroGenics | |
| A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies | NCT00043199 | Colorectal Neop... | Aroplatin (Lipo... | 18 Years - | Aronex Pharmaceuticals | |
| Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma | NCT01394939 | Colorectal Carc... CRC | JX-594 Irinotecan | 18 Years - | SillaJen, Inc. | |
| CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers | NCT02355262 | Breast Carcinom... Cervical Carcin... Colorectal Carc... Health Status U... Human Papilloma... Malignant Neopl... | Informational I... | 18 Years - | OHSU Knight Cancer Institute | |
| Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers | NCT03300570 | Colorectal Carc... | Dolcanatide Laboratory Biom... Placebo Adminis... Questionnaire A... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) | NCT00785122 | Colorectal Carc... | Endoxana, Leuki... Endoxana, Leuki... | 18 Years - | Immatics Biotechnologies GmbH | |
| Three Birds With One Stone | NCT05022511 | Uterine Cervica... Uterine Cervix ... Uterine Cervica... Colorectal Neop... Colorectal Canc... Colorectal Carc... Mass Screening Early Detection... | Screening statu... | 50 Years - 69 Years | University of Aarhus | |
| Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC | NCT03732781 | Peritoneal Carc... Colorectal Carc... | Radspherin | 18 Years - | Oncoinvent AS | |
| Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer | NCT06130826 | Breast Carcinom... Colorectal Carc... | Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Immunotherapy Magnetic Resona... Positron Emissi... Stereotactic Bo... | 18 Years - | City of Hope Medical Center | |
| Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study | NCT03546127 | Colorectal Carc... Soft Tissue Sar... | Next Generation... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
| NBI Versus White Light Endoscopy for Optical Characterization of Neoplastic Polyps in the Colorectum | NCT03679429 | Colon Adenoma Colorectal Carc... Hyperplastic Po... Serrated Adenom... | NBI Function | 40 Years - 90 Years | Technical University of Munich | |
| A Web-Based Dyadic Intervention for Colorectal Cancer | NCT05663203 | Colorectal Carc... | Internet-Based ... Interview Survey Administ... Electronic Heal... | 18 Years - | Emory University | |
| Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin | NCT01466504 | Renal Cell Carc... Hepatocellular ... Colorectal Carc... | skin punch biop... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Enteropathogenic Escherichia Coli (EPEC): Does it Have a Role in Colorectal Tumourigenesis? | NCT02373020 | Enteropathogeni... Colorectal Carc... | colonoscopic bi... | - | Mansoura University | |
| Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases： a Multicenter Cohort Study | NCT04562727 | Colorectal Carc... Chemotherapy Liver Metastase... | Chemotherapy | 18 Years - 80 Years | Chinese PLA General Hospital | |
| Nelfinavir, a Phase I/Phase II Rectal Cancer Study | NCT00704600 | Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | nelfinavir | 18 Years - | Maastricht Radiation Oncology | |
| Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin | NCT01466504 | Renal Cell Carc... Hepatocellular ... Colorectal Carc... | skin punch biop... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer | NCT03597581 | Gastrointestina... Gastrointestina... Colorectal Canc... Colorectal Neop... Colorectal Carc... Gastric Cancer Gastric Neoplas... KRAS Mutation-R... CRC Colorectal Canc... | ompenaclid FOLFIRI Bevacizumab FOLFOX regimen | 18 Years - | Inspirna, Inc. | |
| Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening | NCT04607291 | Colorectal Carc... | Community Healt... Survey Administ... | 50 Years - 75 Years | Roswell Park Cancer Institute | |
| Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC) | NCT01909362 | Colorectal Neop... Advanced Metast... | 18 Years - | US Oncology Research | ||
| ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer | NCT01675128 | Colorectal Neop... Colorectal Carc... Colorectal Tumo... | ISIS 183750 Irinotecan | 18 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
